Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
Bio-Rad Laboratories Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 10
Bio-Rad Laboratories Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Bio-Rad Laboratories Inc, Medical Equipment, Deal Details 14
Asset Purchase 14
Bio-Rad Labs Acquires Flow Cytometer from Propel Labs 14
Bio-Rad Labs Acquires Cell Sorting System From Propel Labs 15
Venture Financing 16
Oxford Impedance Diagnostics Raises USD2.6 Million in Seed Financing 16
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 17
RainDance Technologies Raises US$35 Million In Venture Financing 18
RainDance Technologies Raises US$20 Million In Series E Financing 19
RainDance Technologies Secures US$37.5 Million In Series D Financing 21
Partnerships 22
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 22
AbD Serotec Enters Into Licensing Agreement With Proteomika 23
Bio-Rad Laboratories Enters into Partnership with Illumina 24
RainDance Technologies Enters into Research Agreement with Blood Systems Research Institute 25
Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 26
Bio-Rad Labs Enters Into Co-Development Agreement With Inpeco 27
Bio-Rad Labs Enters Into Co-Marketing Agreement With Lamprogen For Fluorescent Particles 28
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 29
Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 30
Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 31
GnuBIO Enters Into Co-Development Agreement With Montreal Heart Institute 32
Bio-Rad Expands Co-Marketing Agreement With Siemens Medical 33
RainDance Technologies Enters Into Collaboration With Sony DADC 34
RainDance Technologies Enters Into Collaboration With Ambry Genetics 35
RainDance Technologies Enters Into Collaboration With 454 Life Sciences 36
Axis-Shield Signs Option Agreement With Bio-Rad Labs 37
Bio-Rad Labs Enters into Licensing agreement with Globavir Biosciences 38
Equity Offering 39
RainDance Withdraws IPO for USD60 Million 39
Asset Transactions 40
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 40
Acquisition 41
Bio-Rad Labs to Acquire RainDance Technologies 41
Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys For US$70 Million 42
Bio-Rad Labs Acquires QuantaLife For US$162 Million 44
Bio-Rad Labs Acquires Remaining Stake In DiaMed Thailand For US$0.2 Million 45
Bio-Rad Labs Acquires Additional 39% Stake In DiaMed Spain For US$3.4 Million 46
Bio-Rad Laboratories Inc – Key Competitors 47
Bio-Rad Laboratories Inc – Key Employees 48
Bio-Rad Laboratories Inc – Locations And Subsidiaries 49
Head Office 49
Other Locations & Subsidiaries 49
Recent Developments 53
Financial Announcements 53
Nov 02, 2017: Bio-Rad Reports Third-Quarter 2017 Financial Results 53
Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results 54
May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results 55
Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day 56
Feb 23, 2017: VBio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 57
Feb 23, 2017: Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 59
Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent 61
Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results 62
May 05, 2016: Bio-Rad Reports First-Quarter 2016 Currency-Neutral Revenue Growth of Nearly 4 Percent 63
Feb 25, 2016: Bio-Rad Reports Fourth-Quarter and Full-Year 2015 Financial Results 64
Corporate Communications 66
Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors 66
Product News 67
Jun 08, 2017: Bio-Rad Launches CFX Maestro Software for Real-Time PCR Data Analysis 67
Apr 03, 2017: 2017 AACR Annual Meeting Presentations Highlight the Use of Bio-Rad’s Droplet Digital PCR Technology for Liquid Biopsies in Cancer Research 68
Jan 23, 2017: Liquid biopsy researchers to share their strategies for pairing digital PCR and next-generation sequencing at Precision Medicine World Conference 70
Jan 09, 2017: Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases 72
02/25/2016: Bio-Rad Announces CE IVD Marking of Its QX200 Droplet Digital PCR System for Use as an In Vitro Diagnostic 73
Product Approvals 74
Feb 25, 2016: Bio-Rad Announces CE IVD Marking of Its QX200 Droplet Digital PCR System for Use as an In Vitro Diagnostic 74
Other Significant Developments 75
Feb 08, 2016: Bio-Rad Expands its Cell Biology Portfolio with High Performance Flow Cytometer 75
Appendix 76
Methodology 76
About GlobalData 76
Contact Us 76
Disclaimer 76
Bio-Rad Laboratories Inc, Medical Equipment, Key Facts, 2016 2
Bio-Rad Laboratories Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
Bio-Rad Laboratories Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
Bio-Rad Laboratories Inc, Deals By Market, 2011 to YTD 2017 10
Bio-Rad Laboratories Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Bio-Rad Labs Acquires Flow Cytometer from Propel Labs 14
Bio-Rad Labs Acquires Cell Sorting System From Propel Labs 15
Oxford Impedance Diagnostics Raises USD2.6 Million in Seed Financing 16
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 17
RainDance Technologies Raises US$35 Million In Venture Financing 18
RainDance Technologies Raises US$20 Million In Series E Financing 19
RainDance Technologies Secures US$37.5 Million In Series D Financing 21
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 22
AbD Serotec Enters Into Licensing Agreement With Proteomika 23
Bio-Rad Laboratories Enters into Partnership with Illumina 24
RainDance Technologies Enters into Research Agreement with Blood Systems Research Institute 25
Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 26
Bio-Rad Labs Enters Into Co-Development Agreement With Inpeco 27
Bio-Rad Labs Enters Into Co-Marketing Agreement With Lamprogen For Fluorescent Particles 28
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 29
Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 30
Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 31
GnuBIO Enters Into Co-Development Agreement With Montreal Heart Institute 32
Bio-Rad Expands Co-Marketing Agreement With Siemens Medical 33
RainDance Technologies Enters Into Collaboration With Sony DADC 34
RainDance Technologies Enters Into Collaboration With Ambry Genetics 35
RainDance Technologies Enters Into Collaboration With 454 Life Sciences 36
Axis-Shield Signs Option Agreement With Bio-Rad Labs 37
Bio-Rad Labs Enters into Licensing agreement with Globavir Biosciences 38
RainDance Withdraws IPO for USD60 Million 39
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 40
Bio-Rad Labs to Acquire RainDance Technologies 41
Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys For US$70 Million 42
Bio-Rad Labs Acquires QuantaLife For US$162 Million 44
Bio-Rad Labs Acquires Remaining Stake In DiaMed Thailand For US$0.2 Million 45
Bio-Rad Labs Acquires Additional 39% Stake In DiaMed Spain For US$3.4 Million 46
Bio-Rad Laboratories Inc, Key Competitors 47
Bio-Rad Laboratories Inc, Key Employees 48
Bio-Rad Laboratories Inc, Other Locations 49
Bio-Rad Laboratories Inc, Subsidiaries 50